Breast cancer pathology in the era of genomics Review
| Authors: | Wen, H. Y.; Collins, L. C. |
| Review Title: | Breast cancer pathology in the era of genomics |
| Keywords: | treatment response; gene mutation; genetics; histopathology; review; cancer combination chemotherapy; cancer patient; cancer staging; cancer diagnosis; ki 67 antigen; tumor associated leukocyte; biological marker; gene overexpression; breast cancer; gene amplification; epidermal growth factor receptor 2; cancer screening; pathology; breast neoplasms; phosphatidylinositol 3 kinase; cancer therapy; breast tumor; genomics; estrogen receptor; adenoid cystic carcinoma; metastatic breast cancer; fulvestrant; neratinib; multigene family; personalized medicine; phosphatidylinositol 3 kinase inhibitor; programmed death 1 ligand 1; antibody labeling; triple negative breast cancer; pd-l1; estrogen receptor alpha; germline mutation; ki67; immune checkpoint inhibitor; cancer prognosis; genomic medicine; humans; prognosis; human; female; precision medicine; circulating tumor dna; pembrolizumab; alpelisib; malignant neoplasm; ctdna; germline testing; secretory breast carcinoma; mutation profiling; multigene assay; special histologic subtype; adenomyoepithelioma of the breast |
| Journal Title: | Hematology/Oncology Clinics of North America |
| Volume: | 37 |
| Issue: | 1 |
| ISSN: | 0889-8588 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2023-02-01 |
| Start Page: | 33 |
| End Page: | 50 |
| Language: | English |
| DOI: | 10.1016/j.hoc.2022.08.004 |
| PUBMED: | 36435613 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | The MSK Cancer Center Support Grant (P30 CA008748) is acknowledged in PubMed and PDF -- Corresponding author is MSK author: Hannah Y. Wen -- Source: Scopus |
